Silverberg et al. reported that erythropoietin and an iron preparation improved the NYHA class, hospitalization rate, and diuretic requirements in patients with chronic heart failure with an LVEF of 40% or less and Hb levels of between 10 and 11.5 g/dL [17]. This evidence concerns the gene EPO and congestive heart failure.